Vycor Medical (VYCO) Cash from Operations (2010 - 2026)
Vycor Medical's (VYCO) quarterly Cash from Operations came in at 99422.0 in Q1 2026, up 469.47% year-on-year from 17458.54 in Q1 2025, and up 153.42% on a QoQ basis from 39232.0 in Q4 2025.
Vycor Medical (VYCO) Cash from Operations (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Cash from Operations data on file, last reported at 99422.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 469.47% year-over-year to 99422.0 in Q1 2026; TTM through Mar 2026 was 112860.0, a 260.41% increase from a year earlier, with the FY2025 full-year figure at 13471.0, down 122.41% from the prior year.
- Cash from Operations for Q1 2026 stood at 99422.0, up from 39232.0 in the prior quarter.
- Over the last five years, Cash from Operations for VYCO reached as high as 99422.0 in Q1 2026 and fell as low as 78780.0 in Q1 2022.
- Historically, Cash from Operations has averaged 2442.65 across 5 years, with a median of 1887.0 in 2024.
- Across the five-year window, Cash from Operations soared 507.41% in 2024 and plunged 1526.02% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 33354.0 in 2022, then jumped by 116.51% to 5508.0 in 2023, then sank by 795.01% to 38281.0 in 2024, then soared by 202.48% to 39232.0 in 2025, then jumped by 153.42% to 99422.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 99422.0 in Q1 2026, 39232.0 in Q4 2025, and 72427.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 99,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,422.00 |
| Mar 31, 2026 | 99,422.00 |
| Dec 31, 2025 | 39,232.00 |
| Dec 31, 2025 | 39,232.00 |
| Sep 30, 2025 | -72,427.00 |
| Sep 30, 2025 | -72,427.00 |
| Jun 30, 2025 | 46,633.00 |
| Jun 30, 2025 | 46,633.00 |
| Mar 31, 2025 | -26,909.00 |
| Mar 31, 2025 | -26,909.00 |
| Dec 31, 2024 | -38,281.00 |
| Dec 31, 2024 | -38,281.00 |
| Sep 30, 2024 | 10,470.00 |
| Sep 30, 2024 | 10,470.00 |
| Jun 30, 2024 | 86,034.00 |
| Jun 30, 2024 | 86,034.00 |
| Mar 31, 2024 | 1,887.00 |
| Mar 31, 2024 | 1,887.00 |
| Dec 31, 2023 | 5,508.00 |
| Dec 31, 2023 | 5,508.00 |